| # | Drug | Count |
|---|---|---|
| 0 | METOCLOPRAMIDE HYDROCHLORIDE | 140 |
| 1 | METOCLOPRAMIDE | 135 |
| 2 | GABAPENTIN | 96 |
| 3 | ASPIRIN | 92 |
| 4 | ASPIRIN 325 MG | 88 |
| 5 | ASPIRIN 81 MG | 88 |
| 6 | OMEPRAZOLE MAGNESIUM | 84 |
| 7 | PROPRANOLOL HYDROCHLORIDE | 81 |
| 8 | SODIUM OXYBATE | 67 |
| 9 | OMEPRAZOLE | 64 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L-METHIONINE | 1 | 0.1000 |
| 1 | OXYCODONE AND ASPIRIN | 1 | 0.0196 |
| 2 | FRANKINCENSE | 1 | 0.0164 |
| 3 | SULFACETAMIDE SODIUM, SULFUR | 1 | 0.0087 |
| 4 | PRIMIDONE | 58 | 0.0057 |
| 5 | FLUORIDE TOOTHPASTE | 1 | 0.0050 |
| 6 | SEROTONIN | 1 | 0.0037 |
| 7 | NAFARELIN ACETATE | 1 | 0.0037 |
| 8 | PANTHENOL | 1 | 0.0034 |
| 9 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 156 |
| 1 | Benzodiazepine [EPC] | 139 |
| 2 | Anti-epileptic Agent [EPC] | 117 |
| 3 | Corticosteroid [EPC] | 97 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 96 |
| 5 | Proton Pump Inhibitor [EPC] | 85 |
| 6 | Provitamin D2 Compound [EPC] | 68 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 61 |
| 8 | Vitamin C [EPC] | 61 |
| 9 | Mood Stabilizer [EPC] | 56 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 8 | 0.0116 |
| 1 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 3 | 0.0024 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 3 | Provitamin D2 Compound [EPC] | 68 | 0.0023 |
| 4 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 3 | 0.0019 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 10 | 0.0017 |
| 6 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 5 | 0.0013 |
| 7 | Neonatal Fc Receptor Blocker [EPC] | 4 | 0.0009 |
| 8 | Reducing and Complexing Thiol [EPC] | 2 | 0.0008 |
| 9 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 5 | 0.0007 |